Contraindications to<unk>  are active bleeding, increased risk of bradycardia, concomitant therapy of<unk>  and strong cytochrome P-450 3A (CYP3A4) inhibitors and moderate or severe hepatic impairment due to the risk of increased exposure to<unk> .
Ticagrelor
Clopidogrel
Ticlopidine
Prokarin
Rivaroxaban
Eptifibatide
Apixaban
Palladin